DRUG ENANTIOMERS IN CLINICAL PHARMACOLOGY

Authors

  • Kausalyah Krisna Malay Graduate Student, Department of Prosthodontics, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author
  • Ezhilarasan D Assistant professor, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author
  • Revathy Duraisawamy Senior Lecturer, Department of Prosthodontics, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, India. Author
  • Dhanraj Ganapathy Professor and Head Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Chennai – 600077 Tamil Nadu, India Author

DOI:

https://doi.org/10.61841/33jc4c28

Keywords:

enantiomers, chiral drug, thalidomide, stereoisomers, Racemate

Abstract

The single enantiomers are considered to be safer and better alternatives to racemates, which has resulted in a need for developing single isomers as drug products. Most of the drugs in use today are chiral. It is well established that the pharmacological activity is mostly restricted to one of the enantiomers, and the individual enantiomers of racemic drugs frequently differ in their biological effects. In many cases, the inactive enantiomer shows unwanted side effects or even toxic effects. A pharmacological study reveals that there is a need for separating and quantifying enantiomers in biological samples to assess the toxic effects of such drugs. Single-enantiomer products are being re-marketed by so-called the chiral switch process. (Racemate to single enantiomer) 

Downloads

Download data is not yet available.

References

1. Margaret Guo, The Twin Drugs, Journal of Youth and Science, 2011.

2. Davankov, Vadim A. Analytical Chiral Separation Methods. International Union of Pure and Applied Chemistry, 1997. PDF

3. Chen J, Korfmacher WA, Hsieh Y. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations. Journal of Chromatography B. 2005; 820:1–8.

4. Lorenz H, Capla F, Polenske D et al., Crystallization-based separation of enantiomers, Journal of the University of Chemical Technology and Metallurgy 2007: 42: 5-16.

5. Bojarski J, Aboun-Enein HY, Ghanem A. What’s new in chromatographic separations? Current Analytical Chemistry. 2005;1:59–97.

6. Boralli VB, Coelho EB, Cerqueira PM, Lanchote VL. Steroselective analysis of metoprolol and its metabolites in rat plasma with application to oxidative metabolism. Journal of Chromatography B.2005;823:195–202.

7. Carvalho, Cass et al, Brz. J. Chem. Eng. vol. 23(3), July/Sept. 2006

8. Lien Ai Nguyen, Hua He et al, Int J Biomed Sci. 2006 Jun; 2(2): 85–100

9. Raikumar SV. Thalidomide: Tragedy past and promising future. Commentary. Mayo Clinic Proceedings, PubMed.2004

10. Scott, Raymond PW. "Chiral Gas Chromatography." Chromatography Books Online (free access pdfs). Mar. 2011.

11. "Thalidomide." PubMed.gov. National Institute of Health, 3 Feb. 2010.

12. "The Two Enantiomers of Citalopram Bind to the Human Serotonin Transporter in Reversed Orientations." PubMed.gov. National Institute of Health, 3 Feb. 2010.

13. Wisor, Jonathan P., William C. Dement, Lisa Aimone, Michael Williams, and Donna Bozyczko-Coyne. "Armodafinil, the R-enantiomer of Modafinil: Wake-promoting Effects and Pharmacokinetic Profile in the Rat." Pharmacology, Biochemistry, and Behavior 85.3 (2006): 492-99. ScienceDirect - Home. Nov. 2006.

14. Drayer DE. The early history of stereochemistry. In: Wainer IW, editor. Drug stereochemistry. Analytical methods and pharmacology. 2nd. New York: Marcel Dekker Publisher; 1993. pp. 1–24.

15. Waldeck B. Three-dimensional pharmacology, a subject ranging from ignorance to overstatements.Pharmacology and Toxicology. 2003;93(5):203–210.

16. Davies NM, Teng XV. Importance of chirality in drug therapy and pharmacy practice. Implications for psychiatry. Advances in Pharmacy. 2003;1(3):242–252.

17. Stoschitzky K, Lindner W, Zernig G. Racemic beta-blockers-fixed combinations of different drugs.Journal of Clinical and Basic Cardiology. 1998;1(1):15–19.

18. Darrow, Jonathan J. "The Patentability of Enantiomers: Implications for the Pharmaceutical Industry." Stanford Technology Law Review, 2007. Web. 7 Mar. 2011.

19. Matthijs N, Maftouh M, Heyden YV. Screening approach for chiral separation of pharmaceuticals. IV. Polar organic solvent chromatography. Journal of Chromatography B. 2006;830:114–119.

20. Murphy-Poulton SF, Boyle F, Gu XQA, Mather LE. Thalidomide enantiomers: Determination in biological samples by HPLC and vancomycin-CSP. Journal of Chromatography B. 2006;831:48–56.

21. Staroverov SM, Kuznetsov MA, Nesterenko PN, Vasiarov GG, et al. New chiral stationary phase with macrocyclic glycopeptide antibiotic eremomycin chemically bonded to silica. Journal of Chromatography A.2006;1108:263–267.

22. Bhupinder Singh Sekhon, Enantioseparation of chiral drugs—an overview, International Journal of PharmTech Research 2010 2(2).

23. Mann A, Wermuth CG. Prix Nobel de Chimie 2001: William S. Knowles, Ryori Noyori, K. Barry Sharpless. La catalyse asymetrique. Medecine/Sciences. 2001; 17:1230–1232. (French)

Downloads

Published

30.04.2020

How to Cite

Krisna Malay, K., D, E., Duraisawamy, R., & Ganapathy, D. (2020). DRUG ENANTIOMERS IN CLINICAL PHARMACOLOGY. International Journal of Psychosocial Rehabilitation, 24(2), 7498-7504. https://doi.org/10.61841/33jc4c28